Online

Cart
You are here: Home » Products » Pharmaceutical Ingredient » Antiallergic » High Quality USP/EP/BP GMP DMF FDA Brompheniramine Tablets CAS NO 86-22-6 Producer
Share to:

High Quality USP/EP/BP GMP DMF FDA Brompheniramine Tablets CAS NO 86-22-6 Producer

5 0 Reviews

Price: $ 0.08 / Tablet
Quantity:
min order: 1 Tablet
View wholesale prices
  • Quantity Price
  • 1 $0.5
  • 10000 $0.2
  • 100000 $0.1
  • 300000 $0.08
  • AZ032
  • Dideu
  • 86-22-6
  • C16H19BrN2
  • 201-657-8
  • China
  • Brompheniramine Tablets
  • High quality
  • 99.0% Min
  • 99%-101%
  • Tablet
  • Solubility in water
  • 1.0% max
  • 0.5% Max
  • 10 ppm Max
  • H-NMR
  • 0.5% Max
  • Medicine

Our Reference Specification, for more details, pls contact us for COA,MSDS and certification:

Email & Skype: support@dideu.com  Telephone:+86-29-89586682

Mobile:+86-15129568250; Whatsapp: +8615129568250

                                                                                 Brompheniramine Tablets

Action and use

Histamine H1 receptor antagonist; antihistamine.

Definition

Brompheniramine Tablets contain Brompheniramine Maleate.

The tablets comply with the requirements stated under Tablets and with the following requirements.

Content of brompheniramine maleate, C16H19BrN2,C4H4O4

95.0  to 105.0% of the stated amount.

Identification

In the test for Related substances the retention time of the principal peak in the chromatogram obtained with solution (2) is similar to that of the principal peak in the chromatogram obtained with solution (3).




Related substances

Carry out the method for gas chromatography, Appendix III B, using the following solutions. For solution (1) shake a quantity of the powdered tablets containing 20  mg of Brompheniramine Maleate with 5  ml of water for 5  minutes, make the resulting suspension alkaline by adding 13.5m ammonia drop wise, add 2.5  ml of toluene, shake for a further 5  minutes, centrifuge and use the upper, toluene layer. For solution (2) dilute 1  volume of solution (1) to 50  volumes with dichloromethane. Solution (3) is a 0.016% w/v solution of brompheniramine maleate EPCRS in dichloromethane. Solution (4) contains 0.5% w/v of brompheniramine maleate EPCRS and 0.25% w/v of chlorphenamine maleate EPCRS in dichloromethane.


The chromatographic procedure may be carried out using a glass column (2.3 m × 2  mm) packed with acid and base-washed, silanised diatomaceous support (135 µm to 175 µm) (Chromosorb W AW-DMCS is suitable) impregnated with 3% w/w of polymethylphenylsiloxane (50% phenyl) (OV 17 is suitable) and maintaining the temperature of the column at 205° and that of the injection port and the detector at 250°.


Inject 1 µl of each solution. The test is not valid unless, in the chromatogram obtained with solution (4), the resolution factor between the peaks corresponding to brompheniramine and chlorpheniramine is at least 1.5. After injecting solution (1), continue the chromatography for at least 2.5  times the retention time of the principal peak. In the chromatogram obtained with solution (1) the sum of the areas of any secondary peaks is not greater than 1% of the area of the principal peak and no secondary peak has an area greater than 0.4% of the area of the principal peak. Disregard any peak with an area less than 0.1% of that of the principal peak in the chromatogram obtained with solution (1).


Assay

Weigh and powder 20  tablets. Shake a quantity of the powder containing 4  mg of Brompheniramine Maleate with 50  ml of water for 10  minutes, adjust the pH to 11.0 with 0.1m sodium hydroxide and cool to room temperature. Extract the mixture with two 75  ml quantities of petroleum spirit (boiling range, 40° to 60°). Extract the combined extracts with three 50  ml quantities of 1m hydrochloric acid, combine the acidic extracts and add sufficient 1m hydrochloric acid to produce 200  ml. Measure the absorbance of the resulting solution at the maximum at 265  nm, Appendix II B. Calculate the content of C16H19BrN2,C4H4O4  taking 199 as the value of A(1%, 1  cm) at the maximum at 265  nm.

Storage

Brompheniramine Tablets should be protected from light.




The packaging can be customized. the shipping term can be by sea, by air, and sample or small quantity can be shipped by DHL, FEDEX, EMS and TNT.

2316

a) Free sample can be supplied.

b) Guide our clients by professional knowledge and teach them how to use our product after sales.

c) Accept SGS,BV any other third-party inspection before loading.

d) High quality best price Guaranteed.


Why do you choose Dideu Industries as your partner?


A) High quality can be guaranteed. Dideu Industries since 1975 are reputed chemical manufacturer and are Certified by ISO 9001;2015 and have GMP certification.Free sample can be arranged before shipment and SGS,BV and other third party inspection company are accepted before loading.For regular customers, we accept L/C 180 Days, D/P,D/A payment term. If there is any quality problem after goods arrive. Dideu Industries will do fully payment refund.


B) Best price can be guaranteed. As Dideu Industries are integrated pharmaceuticals and chemicals producer, the production cost can be controlled and price will be definitely more competitive than China trading companies.


C) Professional enginners from Dideu Industries will give professional usage guide and services after sales.


D)Dideu Industries work 7×24 hours and your request will be processed by our professional staff in different shift period.


Dideu Industries is one of the largest producer for general chemical, pharmaceutical, nutrition additive, natural extracts, agrochemical and Daily-Use Chemical in China and is headquartered in Shaanxi, China. The Dideu Group comprises subsidiaries and joint ventures in more than 10 countries and operates six integrated production sites and 21 other production sites in Europe, Asia, Australia, Americas and Africa.Its headquarters is located in Xi’An,China. Dideu has customers in over 200 countries and supplies products to a wide variety of industries.


At the end of 2014, the company employed more than 13000 people. In 2014, Group Dideu posted sales of 30 billion and income from operations before special items of about 7.5 billion. The company is currently expanding its international activities with a particular focus on Asia countries. Between 1990 and 2005, the company invested 5.2 billion in Asia, for example in sites near Guangxi,Yunnan, Sichuan, Shaanxi China,Mangalore in India,Bangkok, Thailand,Hanoi, Vietnam etc.


Dideu Industries Consist Of Five Industry Chains:


I)Pharmaceutical Industries

II)Nutrition Additive Industries

III)Daily-Use Chemical Products Industries & Agrochemicals

IV)Environmental Friendly Chemical And Chemurgy Industries

V)Petrochemical Industries

VI)General Chemical Industry


At Dideu, we redefine chemistry to make the world better - and have been doing so for 75 years. As one of the world's leading chemical company, we combine economic success with environmental protection and social responsibility.Through science and innovation we enable our customers in nearly every industry to meet the current and future needs of society.


At Dideu, we create chemistry for a sustainable future with science for a better life.Dideu is a Life Science company with a long and glorious history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. The growing and increasingly aging world population requires improved medical care and an adequate supply of food. Dideu is improving people's quality of life by preventing, alleviating and treating diseases. And we are helping to provide a reliable supply of high quality food, feed and plant based raw materials.We develop new molecules for use in innovative products and solutions to improve health. Our research and development activities are based on a profound understanding of the biochemical processes in living organisms.Our goal is to achieve and sustain leadership positions in our markets, thus creating value for our customers, stockholders and employees. To this end, our strategy is designed to help solve some of the most pressing challenges facing humankind, and by doing this exceptionally well we aim to strengthen the company's earning power. 


We are committed to operating sustainably and addressing our social and ethical responsibilities as a corporate citizen, while at the same time respecting the interests of all our stakeholders. Employees with a passion for innovation enjoy excellent development opportunities at Dideu.Exclusive Focus on the Life Science BusinessesFollowing the economic and legal independence of our former Material Science subgroup.Dideu has charted the course for its successful development as a Life Science company. Our Life Science businesses hold leading positions in innovation driven growth markets. Together they make up a strong, attractive and balanced portfolio that is resistant to fluctuations in demand and to potential risks.The previous structure comprising a strategic management holding company and operational subgroups has thus been replaced by an integrated organization under the umbrella of the strong Dideu brand. The company's operations are managed in three divisions Pharmaceuticals, Consumer Health and Crop Science and the Animal Health business unit.The business continues to be supported by the corporate functions, Dideu Business Services and the service company Currenta, while Technology Services is being integrated into Dideu Group, forming the Engineering and Technology function.


Quality≥1000Unit,please send inquire:
Online Service

Product Inquiry

Customer Reviews

Trade Alert - Delivering the latest product trends and industry news straight to your inbox.
Customer Services
About Us
Chemicalorigin
Trade Services
 ©2020 Dideu Industries Group Limited